This report aims to provide a comprehensive presentation of the global market for Non-alcoholic Steatohepatitis (NASH) Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-alcoholic Steatohepatitis (NASH) Biomarkers. This report contains market size and forecasts of Non-alcoholic Steatohepatitis (NASH) Biomarkers in global, including the following market information:
Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Non-alcoholic Steatohepatitis (NASH) Biomarkers companies in 2022 (%)
The global Non-alcoholic Steatohepatitis (NASH) Biomarkers market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Serum Biomarkers Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Non-alcoholic Steatohepatitis (NASH) Biomarkers include Biopredictive, Quest Diagnostics, Exalenz Bioscience, GENFIT, Siemens Healthineers, ONE WAY LIVER, Prometheus Laboratories and Gilead Sciences, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Non-alcoholic Steatohepatitis (NASH) Biomarkers manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Segment Percentages, by Type, 2022 (%)
Serum Biomarkers
Cytokeratin-18 (CK 18) Marker
Inflammatory Markers
Others
Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Segment Percentages, by Application, 2022 (%)
Hospitals
Diagnostic Centers
Others
Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-alcoholic Steatohepatitis (NASH) Biomarkers revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Non-alcoholic Steatohepatitis (NASH) Biomarkers revenues share in global market, 2022 (%)
Key companies Non-alcoholic Steatohepatitis (NASH) Biomarkers sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Non-alcoholic Steatohepatitis (NASH) Biomarkers sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biopredictive
Quest Diagnostics
Exalenz Bioscience
GENFIT
Siemens Healthineers
ONE WAY LIVER
Prometheus Laboratories
Gilead Sciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non-alcoholic Steatohepatitis (NASH) Biomarkers, market overview.
Chapter 2: Global Non-alcoholic Steatohepatitis (NASH) Biomarkers market size in revenue and volume.
Chapter 3: Detailed analysis of Non-alcoholic Steatohepatitis (NASH) Biomarkers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-alcoholic Steatohepatitis (NASH) Biomarkers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Non-alcoholic Steatohepatitis (NASH) Biomarkers capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Overall Market Size
2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size: 2022 VS 2029
2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales: 2018-2029
3 Company Landscape
3.1 Top Non-alcoholic Steatohepatitis (NASH) Biomarkers Players in Global Market
3.2 Top Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Companies Ranked by Revenue
3.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Companies
3.4 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Companies
3.5 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Non-alcoholic Steatohepatitis (NASH) Biomarkers Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Type
3.8 Tier 1, Tier 2 and Tier 3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Players in Global Market
3.8.1 List of Global Tier 1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Companies
3.8.2 List of Global Tier 2 and Tier 3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size Markets, 2022 & 2029
4.1.2 Serum Biomarkers
4.1.3 Cytokeratin-18 (CK 18) Marker
4.1.4 Inflammatory Markers
4.1.5 Others
4.2 By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue & Forecasts
4.2.1 By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, 2018-2023
4.2.2 By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, 2024-2029
4.2.3 By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share, 2018-2029
4.3 By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales & Forecasts
4.3.1 By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, 2018-2023
4.3.2 By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, 2024-2029
4.3.3 By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share, 2018-2029
4.4 By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Diagnostic Centers
5.1.4 Others
5.2 By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue & Forecasts
5.2.1 By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, 2018-2023
5.2.2 By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, 2024-2029
5.2.3 By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share, 2018-2029
5.3 By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales & Forecasts
5.3.1 By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, 2018-2023
5.3.2 By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, 2024-2029
5.3.3 By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share, 2018-2029
5.4 By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2022 & 2029
6.2 By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue & Forecasts
6.2.1 By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, 2018-2023
6.2.2 By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, 2024-2029
6.2.3 By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share, 2018-2029
6.3 By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales & Forecasts
6.3.1 By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, 2018-2023
6.3.2 By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, 2024-2029
6.3.3 By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, 2018-2029
6.4.2 By Country - North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, 2018-2029
6.4.3 US Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.4.4 Canada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.4.5 Mexico Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, 2018-2029
6.5.2 By Country - Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, 2018-2029
6.5.3 Germany Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.5.4 France Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.5.5 U.K. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.5.6 Italy Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.5.7 Russia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.5.8 Nordic Countries Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.5.9 Benelux Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, 2018-2029
6.6.2 By Region - Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, 2018-2029
6.6.3 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.6.4 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.6.5 South Korea Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.6.6 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.6.7 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, 2018-2029
6.7.2 By Country - South America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, 2018-2029
6.7.3 Brazil Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.7.4 Argentina Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, 2018-2029
6.8.3 Turkey Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.8.4 Israel Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.8.5 Saudi Arabia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.8.6 UAE Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Biopredictive
7.1.1 Biopredictive Company Summary
7.1.2 Biopredictive Business Overview
7.1.3 Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Major Product Offerings
7.1.4 Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales and Revenue in Global (2018-2023)
7.1.5 Biopredictive Key News & Latest Developments
7.2 Quest Diagnostics
7.2.1 Quest Diagnostics Company Summary
7.2.2 Quest Diagnostics Business Overview
7.2.3 Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Major Product Offerings
7.2.4 Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales and Revenue in Global (2018-2023)
7.2.5 Quest Diagnostics Key News & Latest Developments
7.3 Exalenz Bioscience
7.3.1 Exalenz Bioscience Company Summary
7.3.2 Exalenz Bioscience Business Overview
7.3.3 Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Major Product Offerings
7.3.4 Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales and Revenue in Global (2018-2023)
7.3.5 Exalenz Bioscience Key News & Latest Developments
7.4 GENFIT
7.4.1 GENFIT Company Summary
7.4.2 GENFIT Business Overview
7.4.3 GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Major Product Offerings
7.4.4 GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales and Revenue in Global (2018-2023)
7.4.5 GENFIT Key News & Latest Developments
7.5 Siemens Healthineers
7.5.1 Siemens Healthineers Company Summary
7.5.2 Siemens Healthineers Business Overview
7.5.3 Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Major Product Offerings
7.5.4 Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales and Revenue in Global (2018-2023)
7.5.5 Siemens Healthineers Key News & Latest Developments
7.6 ONE WAY LIVER
7.6.1 ONE WAY LIVER Company Summary
7.6.2 ONE WAY LIVER Business Overview
7.6.3 ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Major Product Offerings
7.6.4 ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales and Revenue in Global (2018-2023)
7.6.5 ONE WAY LIVER Key News & Latest Developments
7.7 Prometheus Laboratories
7.7.1 Prometheus Laboratories Company Summary
7.7.2 Prometheus Laboratories Business Overview
7.7.3 Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Major Product Offerings
7.7.4 Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales and Revenue in Global (2018-2023)
7.7.5 Prometheus Laboratories Key News & Latest Developments
7.8 Gilead Sciences
7.8.1 Gilead Sciences Company Summary
7.8.2 Gilead Sciences Business Overview
7.8.3 Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Major Product Offerings
7.8.4 Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales and Revenue in Global (2018-2023)
7.8.5 Gilead Sciences Key News & Latest Developments
8 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Production Capacity, Analysis
8.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Production Capacity, 2018-2029
8.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Production Capacity of Key Manufacturers in Global Market
8.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Non-alcoholic Steatohepatitis (NASH) Biomarkers Supply Chain Analysis
10.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Industry Value Chain
10.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Upstream Market
10.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Non-alcoholic Steatohepatitis (NASH) Biomarkers in Global Market
Table 2. Top Non-alcoholic Steatohepatitis (NASH) Biomarkers Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share by Companies, 2018-2023
Table 5. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Companies, (K Units), 2018-2023
Table 6. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Type
Table 9. List of Global Tier 1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), 2018-2023
Table 15. By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), 2024-2029
Table 16. By Application ? Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), 2018-2023
Table 20. By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), 2024-2029
Table 21. By Region ? Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), 2018-2023
Table 25. By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), 2024-2029
Table 26. By Country - North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, (K Units), 2018-2023
Table 29. By Country - North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, (K Units), 2024-2029
Table 30. By Country - Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, (K Units), 2018-2023
Table 33. By Country - Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, (K Units), 2024-2029
Table 34. By Region - Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, (K Units), 2018-2023
Table 37. By Region - Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, (K Units), 2024-2029
Table 38. By Country - South America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, (K Units), 2018-2023
Table 41. By Country - South America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, (K Units), 2024-2029
Table 46. Biopredictive Company Summary
Table 47. Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Offerings
Table 48. Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Biopredictive Key News & Latest Developments
Table 50. Quest Diagnostics Company Summary
Table 51. Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Offerings
Table 52. Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Quest Diagnostics Key News & Latest Developments
Table 54. Exalenz Bioscience Company Summary
Table 55. Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Offerings
Table 56. Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Exalenz Bioscience Key News & Latest Developments
Table 58. GENFIT Company Summary
Table 59. GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Offerings
Table 60. GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. GENFIT Key News & Latest Developments
Table 62. Siemens Healthineers Company Summary
Table 63. Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Offerings
Table 64. Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Siemens Healthineers Key News & Latest Developments
Table 66. ONE WAY LIVER Company Summary
Table 67. ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Offerings
Table 68. ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. ONE WAY LIVER Key News & Latest Developments
Table 70. Prometheus Laboratories Company Summary
Table 71. Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Offerings
Table 72. Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Prometheus Laboratories Key News & Latest Developments
Table 74. Gilead Sciences Company Summary
Table 75. Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Offerings
Table 76. Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Gilead Sciences Key News & Latest Developments
Table 78. Non-alcoholic Steatohepatitis (NASH) Biomarkers Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 79. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Production by Region, 2018-2023 (K Units)
Table 81. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Production by Region, 2024-2029 (K Units)
Table 82. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Opportunities & Trends in Global Market
Table 83. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Drivers in Global Market
Table 84. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Restraints in Global Market
Table 85. Non-alcoholic Steatohepatitis (NASH) Biomarkers Raw Materials
Table 86. Non-alcoholic Steatohepatitis (NASH) Biomarkers Raw Materials Suppliers in Global Market
Table 87. Typical Non-alcoholic Steatohepatitis (NASH) Biomarkers Downstream
Table 88. Non-alcoholic Steatohepatitis (NASH) Biomarkers Downstream Clients in Global Market
Table 89. Non-alcoholic Steatohepatitis (NASH) Biomarkers Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Non-alcoholic Steatohepatitis (NASH) Biomarkers Segment by Type in 2022
Figure 2. Non-alcoholic Steatohepatitis (NASH) Biomarkers Segment by Application in 2022
Figure 3. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, 2018-2029 (US$, Mn)
Figure 7. Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue in 2022
Figure 9. By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share, 2018-2029
Figure 11. By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share, 2018-2029
Figure 12. By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share, 2018-2029
Figure 15. By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share, 2018-2029
Figure 16. By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share, 2018-2029
Figure 20. By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share, 2018-2029
Figure 21. By Country - North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share, 2018-2029
Figure 22. By Country - North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share, 2018-2029
Figure 23. US Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share, 2018-2029
Figure 28. Germany Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 29. France Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share, 2018-2029
Figure 37. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 41. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share, 2018-2029
Figure 43. By Country - South America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share, 2018-2029
Figure 44. Brazil Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share, 2018-2029
Figure 48. Turkey Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 52. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Non-alcoholic Steatohepatitis (NASH) Biomarkers by Region, 2022 VS 2029
Figure 54. Non-alcoholic Steatohepatitis (NASH) Biomarkers Industry Value Chain
Figure 55. Marketing Channels
